Medline Inc. is 23.0x more valuable than LEMAITRE VASCULAR INC by market capitalization ($49.12 B vs $2.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LMAT | MDLN |
|---|---|---|
| Market cap | $2.13 B | $49.12 B |
| US-listed rank | #2056 | #322 |
| Revenue (latest FY) | $249.60M | $28.43B |
| Net income (latest FY) | $57.70M | $1.16T |
| Net margin | 23.1% | 4069.4% |
| P/E (trailing FY) | 37.0 | 0.0 |
| SEC filings | 1,849 | 103 |
Medline Inc. is 23.0x more valuable than LEMAITRE VASCULAR INC by market capitalization ($49.12 B vs $2.13 B).
In their latest fiscal years, LEMAITRE VASCULAR INC reported $249.60M in revenue while Medline Inc. reported $28.43B.
Full pages: LEMAITRE VASCULAR INC and Medline Inc., or browse the full rankings.